What's New
News
What to Do About…The Decision to Learn One’s Genetic FTD Status
Partners in FTD Care, Winter 2022 Download the full issue (pdf) Deciding whether to learn if one…
What to Know Before Ordering Genetic Testing
Partners in FTD Care, Winter 2022 Download the full issue (pdf) Frontotemporal degeneration is a progressive, terminal…
From a Caregiver’s Perspective: Deciding to Learn One’s Genetic Status
Partners in FTD Care, Winter 2022 Download the full issue (pdf) by A. Parker FTD runs in…
Providing Support to Those Considering Genetic Testing: Guidance for Healthcare Professionals
Partners in FTD Care, Winter 2022 Download the full issue (pdf) For many people facing potential FTD…
The Role of Genetics in FTD: An Overview
Partners in FTD Care, Winter 2022 Download the full issue (pdf) Frontotemporal degeneration (FTD) is a group…
Does It Run in the Family?: The Genetics of FTD
Partners in FTD Care, Winter 2022 Download the full issue (pdf) Most cases of FTD are sporadic,…
New Pharma-Academic Partnership Aims to Advance FTD Treatment Development
Pharmaceutical company GlaxoSmithKline (GSK) and the University of Oxford have teamed up to further advance research and…
Genetic Counselor Discusses Significance of Genetic Testing in “Narrative Matters” Podcast
Genetic counselor Shivani Nazareth discussed in a recent episode of the Narrative Matters podcast why she advocated…
Researchers Gather Recommendations of Practical Treatments to Support Persons with svPPA
Investigators have compiled recommendations for non-pharmacological therapy treatments for persons diagnosed with semantic variant primary progressive aphasia…